ALIGNSCIENCE FDA Monday, March 19, 2018 0.00 Neutral

FDA Approves Unknown Drug — ALIGNSCIENCE PHARMA

AlignScience Pharma announced the FDA’s approval yesterday of its New Drug Application, holding significant market potential for commercialization. This regulatory milestone positions the company to potentially capture a substantial revenue share once the product launches.

View original filing at SEC.gov →

AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

START FREE — 10,000 calls/day, no key needed